Williams & Connolly partner Elise Baumgarten has been named a 2024 Washington, D.C. “Rising Star” by the National Law Journal. According to the publication, the awards are intended to highlight the top litigation and appellate work from the previous year, and finalists stood out for their work guiding clients through high-stakes litigation matters.
Elise has been a key member of several high-profile, successful trial and litigation teams on behalf of some of the largest pharmaceutical companies in the country. Some of her recent notable representations include major trial victories on behalf of Merck in Hatch-Waxman patent litigation, complete trial and appellate victories on behalf of Teva Pharmaceuticals in ANDA litigation, and a trial victory on behalf of Endo Pharmaceuticals in an antitrust class action*.
To see the full list of 2024 National Law Journal finalists and winners, click here.
*All cases vary and none are predictive.